Chemoinformaics analysis of 26,27-Dinorcholesta-5,22-Dien-3-Ol, (3.Beta.,22e)-
Molecular Weight | 356.594 | nRot | 3 |
Heavy Atom Molecular Weight | 316.274 | nRig | 21 |
Exact Molecular Weight | 356.308 | nRing | 4 |
Solubility: LogS | -6.71 | nHRing | 0 |
Solubility: LogP | 6.437 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 66 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 3 |
No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 25 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 69.2237 |
nHD | 1 | BPOL | 40.1283 |
QED | 0.57 |
Synth | 4.377 |
Natural Product Likeliness | 3.047 |
NR-PPAR-gamma | 0.038 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.024 |
Pgp-sub | 0.001 |
HIA | 0.006 |
CACO-2 | -4.622 |
MDCK | 0.0000104 |
BBB | 0.666 |
PPB | 0.985233 |
VDSS | 1.967 |
FU | 0.0184321 |
CYP1A2-inh | 0.105 |
CYP1A2-sub | 0.582 |
CYP2c19-inh | 0.086 |
CYP2c19-sub | 0.931 |
CYP2c9-inh | 0.17 |
CYP2c9-sub | 0.361 |
CYP2d6-inh | 0.045 |
CYP2d6-sub | 0.867 |
CYP3a4-inh | 0.339 |
CYP3a4-sub | 0.458 |
CL | 17.543 |
T12 | 0.03 |
hERG | 0.007 |
Ames | 0.031 |
ROA | 0.038 |
SkinSen | 0.052 |
Carcinogencity | 0.159 |
EI | 0.012 |
Respiratory | 0.352 |
NR-Aromatase | 0.017 |
Antiviral | No |
Prediction | 0.741964 |